The U.S. health regulator has authorized COVID-19 shots from Moderna and Pfizer and its partner BioNTech that target both the original coronavirus and Omicron sub-variants for use in children as young as six months of age. The amended authorization on Thursday from the U.S. #cbc | top stories news #ifttt